Rabbit Polyclonal NAP1L1 antibody. Suitable for IHC-P, WB, ICC/IF and reacts with Human samples. Cited in 5 publications.
View Alternative Names
NRP, NAP1L1, Nucleosome assembly protein 1-like 1, NAP-1-related protein, hNRP
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-NAP1L1 antibody (AB21630)
ICC/IF image of ab21630 stained A431 cells. The cells were 4% formaldehyde fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab21630, 5µg/ml) overnight at +4°C. The secondary antibody (green) was ab96899, DyLight® 488 goat anti-rabbit IgG (H+L) used at a 1/250 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-NAP1L1 antibody (AB21630)
IHC image of ab21630 staining in human skin formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab21630, 5µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
- WB
Unknown
Western blot - Anti-NAP1L1 antibody (AB21630)
For each lane, U2OS cells, either treated or not treated with ionizing radiation, were scraped from a 60 mm dish and added to 75μl of 2X Laemmli buffer. 20μl of these samples were loaded into each lane. ab21630 recognizes a major band of approximately 52 kDa corresponding closely in size to NAP1L1.
Lanes 1 - 2:
Western blot - Anti-NAP1L1 antibody (ab21630) at 1/1000 dilution
Lanes 3 - 4:
Western blot - Anti-NAP1L1 antibody (ab21630) at 1/500 dilution
Lanes 5 - 6:
Western blot - Anti-NAP1L1 antibody (ab21630) at 1/250 dilution
Lanes 1, 3 and 5:
U2OS cell lysate
Lanes 2, 4 and 6:
U2OS cell lysate treated with ionizing radiation
Predicted band size: 45 kDa
Observed band size: 49 kDa,52 kDa
false
- WB
Unknown
Western blot - Anti-NAP1L1 antibody (AB21630)
ab21630 recognizes a major band of approximately 52 kDa corresponding closely in size to NAP1L1. This band is competed away by the addition of the immunizing peptide, suggesting that this is a specific interaction.
All lanes:
Western blot - Anti-NAP1L1 antibody (ab21630) at 1 µg/mL
Lane 1:
HeLa whole cell lysate at 20 µg
Lane 2:
A431 whole cell lysate at 20 µg
Lane 3:
HEK293 whole cell lysate at 20 µg
Lane 4:
HeLa whole cell lysate at 20 µg with Human NAP1L1 peptide (<a href='/en-us/products/unavailable/human-nap1l1-peptide-ab22417'>ab22417</a>)
Lane 5:
A431 whole cell lysate with Human NAP1L1 peptide (<a href='/en-us/products/unavailable/human-nap1l1-peptide-ab22417'>ab22417</a>)
Lane 6:
HEK293 whole cell lysate at 20 µg with Human NAP1L1 peptide (<a href='/en-us/products/unavailable/human-nap1l1-peptide-ab22417'>ab22417</a>)
Secondary
All lanes:
Alexa fluor goat polyclonal to rabbit IgG at 1/10000 dilution
Predicted band size: 45 kDa
Observed band size: 35 kDa,49 kDa,52 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
NAP1L1 contributes to chromatin remodeling by facilitating the assembly and disassembly of nucleosomes. NAP1L1 forms part of a complex that modulates chromatin structure and function influencing gene expression and DNA replication. It interacts with histones contributing to the deposition and removal of histones H2A and H2B making it essential for proper cell cycle progression and regulation.
Pathways
NAP1L1 acts in key signaling interconnected with chromatin modification and cell cycle control. It participates in the histone chaperone pathways influencing chromatin structure dynamics. NAP1L1 associates with proteins like histone H2A-H2B and the chromatin assembly factor CAF-1. These proteins collectively maintain chromatin integrity and regulation during DNA replication and repair processes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
Journal of experimental & clinical cancer research 39:205 PubMed32998758
2020
Applications
Unspecified application
Species
Unspecified reactive species
OncoTargets and therapy 12:11325-11338 PubMed31908497
2019
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 289:8916-30 PubMed24526689
2014
Applications
Unspecified application
Species
Unspecified reactive species
Cell cycle (Georgetown, Tex.) 12:3286-97 PubMed24036545
2013
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 4:589-600 PubMed23911284
2013
Applications
WB
Species
Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com